Patient recruitment methods to evaluate treatment decision making for localized prostate cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 33, Issue 4, 2010, Pages 381-386

  Zeliadt, Steven B ^a,b   Ramsey, Scott D ^a   Van Den Eeden, Stephen K ^c   Hamilton, Ann S ^d   Oakley Girvan, Ingrid ^e   Penson, David F ^f   Fairweather, Megan E ^a   Arora, Neeraj K ^g   Potosky, Arnold L ^h  

^a Fred Hutchinson Cancer Research Center   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c DIVISION OF RESEARCH   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e NORTHERN CALIFORNIA CANCER CENTER   (United States)

^f VANDERBILT UNIVERSITY   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

^h GEORGETOWN UNIVERSITY   (United States)

Author keywords

Decision making; Prostate cancer; Recruitment; Registry

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; DECISION MAKING; ELECTRONIC MEDICAL RECORD; EVALUATION; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING STAFF; PROSTATE CANCER; TREATMENT PLANNING; COST; INFORMATION PROCESSING; MIDDLE AGED; PATIENT SELECTION; PROSTATE TUMOR; RISK; UNITED STATES;

AGED; CALIFORNIA; COSTS AND COST ANALYSIS; DATA COLLECTION; DECISION MAKING; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PATIENT SELECTION; PROSTATIC NEOPLASMS;

EID: 77956646952     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181b215d5     Document Type: Article

References (33)

1. NCCN. National Comprehensive Cancer Network Practice Guidelines in Oncology. Prostate Cancer. 2008;V.1.2008.
2. Wilt TJ, MacDonald R, Rutks I, et al. Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med. 2008;148:435-448.
3. Thompson I, Thrasher JB, Aus G, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol. 2007;177:2106-2131. (Pubitemid 46726449)
4. Middleton RG, Thompson IM, Austenfeld MS, et al. Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological Association. J Urol. 1995;154: 2144-2148.
5. Wasson JH, Cushman CC, Bruskewitz RC, et al. A structured literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research Team. Arch Fam Med. 1993;2:487-493.
6. Holmboe ES, Concato J. Treatment decisions for localized prostate cancer: Asking men what's important. J Gen Intern Med. 2000;15:694-701.
7. Denberg TD, Melhado TV, Steiner JF. Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote. Cancer. 2006;107:620-630.
8. Steginga SK, Occhipinti S, Gardiner RA, et al. Making decisions about treatment for localized prostate cancer. BJU Int. 2002;89:255-260.
9. Fleming C, Wasson JH, Albertsen PC, et al. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. JAMA. 1993;269:2650-2658.
10. O'Rourke ME. Decision making and prostate cancer treatment selection: A review. Semin Oncol Nurs. 2001;17:108-117.
11. Zeliadt SB, Ramsey SD, Penson DF, et al. Why do men choose one treatment over another? A review of patient decision making for localized prostate cancer. Cancer. 2006;106:1865-1874.
12. O'Rourke ME. Choose wisely: Therapeutic decisions and quality of life in patients with prostate cancer. Clin J Oncol Nurs. 2007;11:401-408.
13. Berry DL, Ellis WJ, Woods NF, et al. Treatment decision-making by men with localized prostate cancer: The influence of personal factors. Urol Oncol. 2003;21:93-100.
14. Pickles T, Ruether JD, Weir L, et al. Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance. BJU Int. 2007;100:544-551.
15. Feldman-Stewart D, Brundage MD, Manen LV, et al. Patient-focused decision- making in early-stage prostate cancer: Insights from a cognitively based decision aid. Health Expect. 2004;7:126-141.
16. Feldman-Stewart D, Brundage MD, Nickel JC, et al. The information required by patients with early-stage prostate cancer in choosing their treatment. BJU Int. 2001;87:218-223.
17. Gwede CK, Pow-Sang J, Seigne J, et al. Treatment decision-making strategies and influences in patients with localized prostate carcinoma. Cancer. 2005; 104:1381-1390.
18. Crawford ED, Bennett CL, Stone NN, et al. Comparison of perspectives on prostate cancer: Analyses of survey data. Urology. 1997;50:366-372.
19. O'Rourke ME, Germino BB. Prostate cancer treatment decisions: A focus group exploration. Oncol Nurs Forum. 1998;25:97-104.
20. O'Rourke ME. Narrowing the options: The process of deciding on prostate cancer treatment. Cancer Invest. 1999;17:349-359.
21. Miles BJ, Giesler B, Kattan MW. Recall and attitudes in patients with prostate cancer. Urology. 1999;53:169-174.
22. Diefenbach MA, Dorsey J, Uzzo RG, et al. Decision-making strategies for patients with localized prostate cancer. Semin Urol Oncol. 2002;20:55-62.
23. Han M, Partin AW, Zahurak M, et al. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol. 2003;169:517-523.
24. SEER. Surveillance, Epidemiology, End Results. 2007 [updated 2007; cited]; Available at: Http://seer.cancer.gov.
25. Rimer BK, Schildkraut JM, Lerman C, et al. Participation in a women's breast cancer risk counseling trial. Who participates? Who declines? High Risk Breast Cancer Consortium. Cancer. 1996;77:2348-2355.
26. Satia JA, Galanko JA, Rimer BK. Methods and strategies to recruit African Americans into cancer prevention surveillance studies. Cancer Epidemiol Biomarkers Prev. 2005;14:718-721.
27. Eaden J, Mayberry MK, Mayberry JF. Questionnaires: The use and abuse of social survey methods in medical research. Postgrad Med J. 1999;75: 397-400.
28. Katz SJ, Lantz PM, Janz NK, et al. Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol. 2005;23:5526-5533.
29. Beskow LM, Sandler RS, Weinberger M. Research recruitment through US central cancer registries: Balancing privacy and scientific issues. Am J Public Health. 2006;96:1920-1926.
30. Meyer BJ, Talbot AP, Ranalli C. Why older adults make more immediate treatment decisions about cancer than younger adults. Psychol Aging. 2007; 22:505-524.
31. Chin Feman SP, Nguyen LT, Quilty MT, et al. Effectiveness of recruitment in clinical trials: An analysis of methods used in a trial for irritable bowel syndrome patients. Contemp Clin Trials. 2007.
32. Hinshaw LB, Jackson SA, Chen MY. Direct mailing was a successful recruitment strategy for a lung-cancer screening trial. J Clin Epidemiol. 2007;60:853-857.
33. Donovan JL, Peters TJ, Noble S, et al. Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study). J Clin Epidemiol. 2003;56:605-609.